Sl. Pichla et al., THE CRYSTAL-STRUCTURE OF A FAB FRAGMENT TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE, Journal of structural biology, 119(1), 1997, pp. 6-16
The GD2 ganglioside is a cell-surface component that appears on the su
rface of metastatic melanoma cells and is a marker for the progression
of the disease. The ME36.1 monoclonal antibody binds to the GD2 gangl
ioside and has shown potential as a therapeutic antibody. ME36.1 is a
possible alternative therapy to radiation, which is often ineffective
in late-stage melanoma. The crystal structure of the Fab fragment of M
E36.1 has been determined using molecular replacement and refined to a
n R factor of 20.4% at 2.8 Angstrom resolution. The model has good geo
metry with root-mean-square deviations of 0.008 Angstrom from ideal bo
nd lengths and 1.7 degrees from ideal bond angles. The crystal structu
re of the ME36.1 Fab shows that its complementarity determining region
forms a groove-shaped binding site rather than the pocket-type observ
ed in other sugar binding Fabs. Molecular modeling has placed a four-r
esidue sugar, representative of GD2, in the antigen binding site. The
GD2 sugar moiety is stabilized by a network of hydrogen bonds that def
ine the specificity of ME36.1 toward its antigen. (C) 1997 Academic Pr
ess.